Diabetes Articles
What is gestational diabetes?
The term gestational diabetes (GD) refers to diabetes that is diagnosed during pregnancy. Current estimates place between 3% to 25% of all pregnant women to be at risk for gestational diabetes, which has significant consequences for both the fetus and the mother. Many women also develop type 2 diabetes mellitus after GD, which further compounds the need to identify the risks associated with this disease. To date, there has been no causal link established between sugar consumption and the development of GD because sugar consumption plays close to no role in influencing insulin resistance, which is the key mechanism that establishes GD.
Risks of gestational diabetes
As a pregnancy progresses throughout the trimesters, insulin resistance tends to increase in mothers that have GD. High blood sugar levels occur when the insulin-producing pancreas can no longer compensate for the resistance. There are, however, a multitude of known risk factors, and these include being under the age of 25 years; a history of type 2 diabetes mellitus or previous gestational diabetes; race, with those of African heritage particularly at risk; being overweight; having hypertension; polycystic ovarian syndrome; and chronic steroid consumption. These risk factors are used for early detection in the assessment of pregnant mothers who are prone to GD. Tackling the presence of high blood sugar levels is crucial in the early stages of fetal development, so as to ensure the organs develop normally. As mentioned above, being overweight or obese with a Body Mass Index (BMI) above 25 kg/m2 has significant bearing in predisposing pregnant women to suffer from GD.
One reason for the misconception that sugar causes GD may come from the fact that there may be excess carbohydrate intake in individuals with the disease. Excessive consumption of dessert foods, such as cake, cookies, and other confectionaries that tend to be major part of the diets of some obese individuals can lead to the false assumption that sugar and gestational diabetes have a causal link.
—
Disclaimer: Please note that the contents of this community article are strictly for informational purposes and should not be considered as medical advice. This article, and other community articles, are not written or reviewed for medical validity by Canadian Insulin or its staff. All views and opinions expressed by the contributing authors are not endorsed by Canadian Insulin. Always consult a medical professional for medical advice, diagnosis, and treatment.
Can Metformin Prevent Blindness in Diabetic Individuals?
Summary: Metformin, a diabetes medication, may help prevent vision loss in diabetic individuals. Research shows it reduces the risk of diabetic retinopathy, age-related macular degeneration, and glaucoma through its anti-inflammatory…
Metformin may Reduce Uterine Fibroids in Women with Type 2 Diabetes
Summary: Recent research suggests that metformin, a common medication for type 2 diabetes, may reduce the risk of developing uterine fibroids in women. A study of nearly 22,000 Taiwanese women…
Exploring Tirzepatide’s Potential in Treating Multiple Sclerosis and Neuroinflammatory Disorders
Summary: Discover how tirzepatide, initially approved for type 2 diabetes and weight loss, may offer new therapeutic avenues for multiple sclerosis (MS) and neuroinflammatory disorders.Tirzepatide, a groundbreaking medication originally approved…
Retatrutide Clinical Trials: A Look at Safety, Efficacy, and Outcomes
Summary: Retatrutide clinical trials have demonstrated promising results in managing obesity and metabolic diseases, showing significant weight loss and improvements in cardiovascular and liver health. Its triple-action mechanism, targeting GLP-1,…
Managing Retatrutide Cost: Tips for Affording This New Medication
Summary: Managing the Retatrutide cost can be challenging due to factors like research and development, manufacturing, and market exclusivity. However, patients can explore options like patient assistance programs, prescription discount…
Mazdutide vs Retatrutide: Comparing the Next-Gen Diabetes Treatments
Summary: Mazdutide vs Retatrutide both offer significant benefits for managing type 2 diabetes and obesity. While Mazdutide targets two receptors for blood sugar control and weight loss, Retatrutide’s triple-receptor mechanism…
Retatrutide Dosage Recommendations: What Patients Should Know
Summary: Retatrutide is a groundbreaking multi-receptor agonist offering hope in diabetes and obesity management. Understanding Retatrutide dosage is critical for achieving optimal results. This guide explains the dosage process, from…
What is Retatrutide, and Why Is It Creating Buzz in Diabetes Research?
Summary: Retatrutide is an innovative multi-receptor agonist, widely regarded as a breakthrough in diabetes and weight management. By targeting GLP-1, GIP, and glucagon receptors, it effectively addresses multiple metabolic challenges.…
Metformin: A Promising Ally in the Fight Against Colorectal Cancer
Summary: Metformin, primarily a diabetes medication, shows potential in treating colorectal cancer (CRC) due to its ability to regulate gene expression and metabolic pathways. Recent studies highlight its anti-cancer effects…
Does Janumet Cause Weight Loss? Its Impact on Diabetes Management
Summary: Wondering, does Janumet cause weight loss? While Janumet primarily aids in blood sugar management, its metformin component may offer modest weight loss benefits for some people with type 2…
Understanding Janumet Dosage: How to Take It Safely and Effectively
Summary: Proper Janumet dosage is key to safely and effectively managing type 2 diabetes. This dual-action medication combines sitagliptin and metformin to target blood sugar levels throughout the day. Understanding…
Unlock the Benefits of Janumet Medication for Type 2 Diabetes
Summary: Janumet medication combines sitagliptin and metformin to provide effective blood sugar control for type 2 diabetes. Its dual-action mechanism targets fasting and post-meal glucose levels, offering comprehensive management. With…